Catalog

von Willebrand Disease and a Current Update of the Thrombotic Symptoms Webinar
Online
Added:

FREE FOR MEMBERS!
Description: In 1926, Dr. Erik Adolf von Willebrand first described an inherited bleeding disorder that afflicted an entire family in his native Finland. Since then, there have been several different types of von Willebrand Disease (vWD) identified which are all caused by abnormalities in the quantity or function of von Willebrand Factor (vWF), both named in honour of Dr. von Willebrand's pioneering work. This lecture will provide a comprehensive history of the discovery and classification of vWD subtypes, as well as a current review of the role vWF plays in the thrombotic symptoms of a subset of COVID-19 patients.
Start Date: Upon registration
Completion: Up to 52 weeks
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded

About this item

FREE FOR MEMBERS!

Description: In 1926, Dr. Erik Adolf von Willebrand first described an inherited bleeding disorder that afflicted an entire family in his native Finland.  Since then, there have been several different types of von Willebrand Disease (vWD) identified which are all caused by abnormalities in the quantity or function of von Willebrand Factor (vWF), both named in honour of Dr. von Willebrand's pioneering work.  This lecture will provide a comprehensive history of the discovery and classification of vWD subtypes, as well as a current review of the role vWF plays in the thrombotic symptoms of a subset of COVID-19 patients.

Start Date: Upon registration

Completion: Up to 52 weeks

Course/Activity Information

At the end of this webinar you will be able to:

  • Provide a historical account of the discovery of von Willebrand Disease (vWD)
  • Describe the function of von Willebrand Factor (vWF), an important procoagulant enzyme
  • Provide a current update of the role of vWF in the thrombotic symptoms of COVID-19 patients

 

Speaker: Terence Litavec, MLT

Terence Litavec has worked as a medical laboratory technologist since 2004 and has served as the MLT Director of the BCSLS. He currently works in the Hematology Department at LifeLabs in Burnaby.  Before that, he worked at Burnaby Hospital and Kelowna General Hospital, as well as Tacoma General Hospital and PhenoPath Laboratories, both in Washington State.  He is certified by both the CSMLS and the ASCP.  He is a certified specialist in hematology and coagulation, and he also has bench experience working in immunohistochemistry, flow cytometry, transfusion services, and some molecular methods such as FISH and PCR.  He has always had a passion for teaching, and he has written and presented numerous educational lectures throughout Canada.

 

Recorded: February 3, 2021

 

PEP hours: 1.0

CPS credits: 0

*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.

Close
Shopping Cart
Total:  Close

Loading Shopping Cart Items...